Tnf Inhibitors to Reduce Mortality in HIV-1 Infected PAtients With Tuberculosis meNIngitis

NCT05590455 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

130

Enrollment

OTHER_GOV

Sponsor class

Conditions

Tuberculous Meningitis
HIV I Infection

Interventions

DRUG: Adalimumab Injection

Sponsor

ANRS, Emerging Infectious Diseases